GPT Healthcare IPO: Latest subscription, GMP on Day 2
The Initial Public Offering (IPO) of GPT Healthcare Ltd, a regional healthcare company mainly operating in Eastern India, has seen a moderate subscription rate on its second day of trading.
The IPO, which made its debut at the stock market on Thursday, February 22, 2024, witnessed a subscription status of 37 per cent on its first day.
Breaking down the subscription, the retail portion of the issue received a higher interest, with a subscription rate of 66 per cent. However, the non-institutional investors (NIIs) portion saw a modest subscription of 18 per cent, while the Qualified Institutional Buyer (QIBs) portion is yet to garner any bids.
As of noon on Friday, February 23, 2024, the subscription stands at 0.64 times, indicating a lukewarm response from investors. In the retail category, the IPO saw a subscription of 1.07 times, while the QIB category remained unsubscribed, and the NII category recorded a subscription of 0.48 times by 2:15 pm.
GPT Healthcare IPO GMP
The Grey Market Premium (GMP) for GPT Healthcare IPO stands at Rs 19, suggesting that the share price is trading at a premium of Rs 19 in the grey market. Considering the upper end of the IPO price band and the current premium in the grey market, the expected listing price for GPT Healthcare IPO is indicated at Rs 205 per share, reflecting a 10.22 per cent increase over the IPO price of Rs 186.
The IPO, valued at Rs 525.14 crores, comprises a fresh issue of 0.22 crore shares amounting to Rs 40.00 crores and an offer for sale of 2.61 crore shares amounting to Rs 485.14 crores.
